Viewing Study NCT03030235


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-02-25 @ 10:05 PM
Study NCT ID: NCT03030235
Status: COMPLETED
Last Update Posted: 2022-10-19
First Post: 2017-01-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Sponsor: Saint Luke's Health System
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Heart Failure With Preserved Systolic Function View
Keywords:

Keywords

Keyword Brief Keyword Text View
None heart failure View
None dapagliflozin View
None SGLT-2 inhibitors View